Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Drug Safety Crisis Response My Core Decision I will recommend full, proactive disclosure. Waiting is not a viable option. Here's why: Every day of delay adds approximately 22 patients exposed to an undisclosed risk Regulatory agencies treat delayed voluntary disclosure far more favorably than…Read the full answer
As CEO, my overriding duty is to balance patient safety, legal/regulatory compliance, fiduciary responsibility, and long-term corporate survival. A 1-in-8,000 risk of liver failure is rare but severe, potentially fatal, and materially unexpected relative to the current label.Read the full answer